Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07311044 · ClinicalTrials.gov registry record

CVD/PH and Voice Characteristics

A clinical trial of Cardiovascular Diseases and Pulmonary Hypertension, sponsored by Mayo Clinic.

Recruiting
Registry status
7,000
Enrollment target
1
Study location

NCT07311044 is a study of Cardiovascular Diseases and Pulmonary Hypertension that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 7,000 participants, below the 26,951-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07311044, a study of Cardiovascular Diseases and Pulmonary Hypertension, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
7,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the association between patient voice signal characteristics and the presence and severity of pulmonary hypertension in patients referred for elective clinically indicated echocardiography for at Mayo Clinic MN.

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 7,000 participants
Start Date 2021-01-08
Est. Completion 2027-01

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT07311044

The ClinicalTrials.gov registry entry for NCT07311044 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 7,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,951-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (74% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 0 interventions.

NCT07311044 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07311044 about?

NCT07311044 is a clinical study titled "CVD/PH and Voice Characteristics". The purpose of this study is to determine the association between patient voice signal characteristics and the presence and severity of pulmonary hypertension in patients referred for elective clinically indicated echocardiography for at Mayo Clinic MN.

What is the current status of trial NCT07311044?

This trial is currently recruiting. The enrollment target is 7,000 participants. The study started on 2021-01-08. Estimated completion is 2027-01.

What conditions does trial NCT07311044 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Pulmonary Hypertension.

Who is sponsoring clinical trial NCT07311044?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07311044 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.